Killer Immunoglobulin-like Receptor (KIR) Incompatible Unrelated Donor Hematopoietic Cell Transplantation (HCT) for Acute Myelogenous Leukemia (AML) with Monosomy 7 -5/5q- High FLT3-ITD AR or Refractory and Relapsed AML in Children: A Children?s Oncology Group (COG) Study
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The primary goal of this study is to see whether specific cell protein mismatches (KIR receptor-ligand) may improve stem cell transplant results.
Description
The primary goal of this study is to see whether specific cell protein mismatches (KIR receptor-ligand) may improve stem cell transplant results.
Details
| Condition | Leukemia |
|---|---|
| Age | 30years or below |
| Clinical Study Identifier | TX3781 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.